These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8680650)
1. Potentiation of antiproliferative effects of monoclonal antibody Lym-1 and immunoconjugate Lym-1-gelonin on human Burkitt's lymphoma cells with gamma-interferon and tumor necrosis factor. O'Boyle KP; Colletti D; Mazurek C; Wang Y; Ray SK; Diamond B; Rosenblum MG; Epstein AL; Shochat D; Dutcher JP J Immunother Emphasis Tumor Immunol; 1995 Nov; 18(4):221-30. PubMed ID: 8680650 [TBL] [Abstract][Full Text] [Related]
2. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors. Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356 [TBL] [Abstract][Full Text] [Related]
3. A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin gelonin. Rosenblum MG; Murray JL; Cheung L; Rifkin R; Salmon S; Bartholomew R Mol Biother; 1991 Mar; 3(1):6-13. PubMed ID: 1906286 [TBL] [Abstract][Full Text] [Related]
4. A gelonin-containing immunotoxin directed against human breast carcinoma. Rosenblum MG; Zuckerman JE; Marks JW; Rotbein J; Allen WR Mol Biother; 1992 Sep; 4(3):122-9. PubMed ID: 1445665 [TBL] [Abstract][Full Text] [Related]
5. Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells. Liu C; DeNardo G; Tobin E; DeNardo S Cancer Biother Radiopharm; 2004 Oct; 19(5):545-61. PubMed ID: 15650447 [TBL] [Abstract][Full Text] [Related]
6. A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2. Mujoo K; Reisfeld RA; Cheung L; Rosenblum MG Cancer Immunol Immunother; 1991; 34(3):198-204. PubMed ID: 1756537 [TBL] [Abstract][Full Text] [Related]
7. Toxin-targeted design for anticancer therapy. II: Preparation and biological comparison of different chemically linked gelonin-antibody conjugates. Delprino L; Giacomotti M; Dosio F; Brusa P; Ceruti M; Grosa G; Cattel L J Pharm Sci; 1993 Jul; 82(7):699-704. PubMed ID: 8360843 [TBL] [Abstract][Full Text] [Related]
8. Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity. Pagliaro LC; Liu B; Munker R; Andreeff M; Freireich EJ; Scheinberg DA; Rosenblum MG Clin Cancer Res; 1998 Aug; 4(8):1971-6. PubMed ID: 9717827 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal Lym-1 antibody-dependent lysis of B-lymphoblastoid tumor targets by human complement and cytokinine-exposed mononuclear and neutrophilic polymorphonuclear leukocytes. Ottonello L; Morone P; Dapino P; Dallegri F Blood; 1996 Jun; 87(12):5171-8. PubMed ID: 8652830 [TBL] [Abstract][Full Text] [Related]
10. Use of blue-sepharose for purification of immunotoxin containing type 1 ribosome-inactivating protein, gelonin. Masuda K; Hirano K; Takagishi Y Biomed Chromatogr; 1994; 8(1):9-13. PubMed ID: 7510554 [TBL] [Abstract][Full Text] [Related]
11. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin. Rosenblum MG; Marks JW; Cheung LH Cancer Chemother Pharmacol; 1999; 44(4):343-8. PubMed ID: 10447583 [TBL] [Abstract][Full Text] [Related]
12. Purification of immunotoxins containing the ribosome-inactivating proteins gelonin and momordin using high performance liquid immunoaffinity chromatography compared with blue sepharose CL-6B affinity chromatography. Cumber AJ; Henry RV; Parnell GD; Wawrzynczak EJ J Immunol Methods; 1990 Dec; 135(1-2):15-24. PubMed ID: 2273254 [TBL] [Abstract][Full Text] [Related]
13. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma. Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030 [TBL] [Abstract][Full Text] [Related]
14. The antileukemic efficacy of an immunotoxin composed of a monoclonal anti-Thy-1 antibody disulfide linked to the ribosome-inactivating protein gelonin. Scott CF; Goldmacher VS; Lambert JM; Chari RV; Bolender S; Gauthier MN; Blättler WA Cancer Immunol Immunother; 1987; 25(1):31-40. PubMed ID: 3496157 [TBL] [Abstract][Full Text] [Related]
15. Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates. Sivam G; Pearson JW; Bohn W; Oldham RK; Sadoff JC; Morgan AC Cancer Res; 1987 Jun; 47(12):3169-73. PubMed ID: 3495329 [TBL] [Abstract][Full Text] [Related]
16. Effect of gelonin immunoconjugate with monoclonal antibody MSN-1 to endometrial adenocarcinoma on antigen-producing tumor cells in vivo. Kaneta Y; Tsukazaki K; Kubushiro K; Aoki R; Sakayori M; Ueda M; Nozawa S Jpn J Cancer Res; 1998 May; 89(5):583-8. PubMed ID: 9685864 [TBL] [Abstract][Full Text] [Related]
17. Internalization and shedding of Lym-1 monoclonal antibody following interaction with surface antigens of a cultured human B cell lymphoma. Wang BS; Kelley KA; Lumanglas AL; Zimmer AM; Durr FE Cell Immunol; 1989 Oct; 123(2):283-93. PubMed ID: 2790963 [TBL] [Abstract][Full Text] [Related]
18. Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to target resistant cells. Rosenblum MG; Cheung L; Kim SK; Mujoo K; Donato NJ; Murray JL Cancer Immunol Immunother; 1996 Feb; 42(2):115-21. PubMed ID: 8620520 [TBL] [Abstract][Full Text] [Related]
19. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis. DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487 [TBL] [Abstract][Full Text] [Related]
20. Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31-gelonin. Selbo PK; Sivam G; Fodstad O; Sandvig K; Berg K Int J Cancer; 2000 Sep; 87(6):853-9. PubMed ID: 10956397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]